Consolidate Heart, Brave Practice, Innovative Level Professor Semenza Attends Anji CGT Seminar

On December 3rd, Professor Greg Semenza was invited to attend the "2023 Anji Liangshan International Cell and Gene Therapy (CGT) Industry Innovation Seminar" co organized by Zhejiang Quansheng Biotechnology Co., Ltd. We talked about the development of cell and gene therapy industry with Pei Gang, Yang Shengli, Li Jinsong, Zhang Dan and other four academicians of the CAS Member, as well as 150 clinical experts, representatives of leading enterprises and investment institutions.

Quansheng is committed to research in regenerative medicine

Boosting transformation and benefiting the people

Quansheng Biotechnology is a company that focuses on innovative cell drug research and development, cell storage, and preparation technologies

High tech enterprises, relying on cell technology for health management, disease treatment, etc., are committed to promoting high-quality clinical research of stem cell products, always with the ultimate goal of safeguarding national health.

The core team has decades of rich experience in global drug innovation, and has participated in the research and commercial production of more than ten marketed biopharmaceuticals. Collaborate with domestic and foreign scientists, including Nobel laureates, to accelerate the development of new drugs and promote the advancement of advanced technologies in the field of regenerative medicine.

In the future, Quansheng Biotechnology will continue to play the role of a major scientific research enterprise, contribute high-quality technological innovation achievements to society, and create greater social value in clinical applications and market promotion.

Gregg L. Semenza

Nobel Prize in Physiology or Medicine

Professor Gregg L. Semenza is mainly engaged in research in the field of hypoxia inducible factors (HIF), and has published over 400 papers with over 100000 citations. He is also a member of the National Academy of Sciences and the National Academy of Medicine in the United States, and a professor in the Department of Genetics at Johns Hopkins University School of Medicine. In 2016, he was awarded the Lasker Basic Medical Research Award. In 2019, Professor Gregg L. Semenza, along with two other professors, William Kaelin and Peter Ratcliffe, was awarded the Nobel Prize in Physiology or Medicine.